Ne­go­ti­a­tions or price con­trols? Sen­ate Fi­nance Com­mit­tee splits along par­ty lines over drug prices

The now dead Build Back Bet­ter Act may be the clos­est the De­moc­rats ever get to Medicare drug price ne­go­ti­a­tions.

Al­though Sen­ate Fi­nance Chair Ron Wyden (D-OR) sought to res­ur­rect Medicare ne­go­ti­a­tions in a hear­ing on Wednes­day, Re­pub­li­cans in the com­mit­tee made clear their op­po­si­tion to ne­go­ti­at­ing, es­pe­cial­ly as they sought to con­vince view­ers that the term “ne­go­ti­a­tions” is ac­tu­al­ly clos­er to price con­trols.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER